Notes to SEFA
Title: Basis of Presentation
Accounting Policies: Expenditures reported in the schedule of expenditures of federal awards are reported on the modified accrual basis of accounting, except for subrecipient expenditures, which are recorded on cash basis. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The City has not elected to use the 10% de minimis cost rate.
The accompanying schedule of expenditures of federal awards includes the federal grant activity of the City of Fargo (the City) under programs of the federal government for the year ended December 31, 2023. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of the City, it is not intended to and does not present the financial position, changes in net position or fund balance, or cash flows of the City.
Title: Loan Programs
Accounting Policies: Expenditures reported in the schedule of expenditures of federal awards are reported on the modified accrual basis of accounting, except for subrecipient expenditures, which are recorded on cash basis. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The City has not elected to use the 10% de minimis cost rate.
As of December 31, 2023, the City’s liability relating to the Storm Sewer and Waste Water Expansion ‐ State Revolving Fund (SRF) Loans (CFDA #66.458) is $182,789,420. The City’s liability related to the Drinking Water Expansion ‐ State Revolving Fund (SRF) Loans (CFDA #66.468) is $108,408,394.